Sputum Proteomics reveals unique signatures linked to key outcomes in cystic fibrosis trials.
S. Pottenger, D. Nazareth, D. Wat, B. Bellina, M. Langini, M. Walshaw, D. R. Neill, C. Schwarz, F. Frost, J. L. Fothergill
This study identifies sputum proteomic signatures linked to FEV1 and QoL changes in cystic fibrosis trials, revealing distinct physiological mechanisms.
bioRxiv · Jul 23, 2024 · PreprintImmunology